Biorce

Category

AI & Machine Learning

Launched

August 12, 2026

Stage

Series A

Website

biorce.com

Clinical trials are notoriously slow, expensive, and paper heavy. A single protocol amendment can cost millions and delay a drug's path to market by months. Yet the industry has relied on point solutions—separate tools for protocol design, feasibility, patient recruitment, and regulatory submission—that don't talk to each other. Biorce, a Series A startup, is making a bold claim: it has built the first operating system for clinical development, and it's powered by explainable AI. The company's product, Aika, is positioned not as another SaaS tool but as a new operating model for the entire trial lifecycle. The website's language is telling: "From protocol to submission," "the first operating system for clinical development," and "a new operating model for clinical development that will shift how trials are run." This is not incremental improvement; it's a rebranding of how clinical trials should be orchestrated.